1. DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer

   • C. Ghelardini
   • N. Galeotti
   • A. Bartolini

   Original Article Pages: 419 - 426

2. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area

   • Maud Leonetti
   • Philippe Brun
   • Marie-Françoise Suaud-Chagny

   Original Article Pages: 427 - 433

3. Effects of prodelphinidins isolated from Ribes nigrum on chondrocyte metabolism and COX activity

   • Nancy Garbacki
   • Luc Angenot
   • Monique Tits

   Original Article Pages: 434 - 441

4. Pharmacological characterisation of [(pX)Phe⁴]nociceptin(1-13)amide analogues

   • Raffaella Bigoni
   • Daniela Rizzi
   • Girolamo Calo'

   Original Article Pages: 442 - 449

5. Pharmacological characterisation of [(pX)Phe⁴]nociceptin(1-13)NH₂ analogues

   • Anna Rizzi
   • Maria Salis
   • Girolamo Calo'

   Original Article Pages: 450 - 456

6. Inhibition of transport function and desipramine binding at the human noradrenaline transporter by N-ethylmaleimide and protection by substrate analogs

   • Kevin F. Foley
   • Nicholas V. Cozzi

   Original Article Pages: 457 - 461

7. Failure to detect in vivo inverse agonism of the 5-HT_1B receptor antagonist SB-224289 in 5-HT-depleted guinea-pigs

   • Carina Stenfors
   • Svante B. Ross

   Original Article Pages: 462 - 467

8. Signalling components involved in the coupling of α₁-adrenoceptors to phospholipase D in neonatal rat cardiac myocytes

   • Nils Gosau
   • Mercedeh Fahimi-Vahid
   • Thomas Wieland

   Original Article Pages: 468 - 476

9. Peripherally applied candesartan inhibits central responses to angiotensin II in conscious rats

   • P. Gohlke
   • T. Kox
   • J. Culman

   Original Article Pages: 477 - 483